Oncogenic RET Kinase Domain Mutations Perturb the Autophosphorylation Trajectory by Enhancing Substrate Presentation In trans
about
Multiple endocrine neoplasia type 2 kindred with novel tandem RET mutations: Case report with an applied in silico mutational tolerance analysis.Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility.Kinetic regulation of multi-ligand binding proteins.Differential recruitment of E3-ubiquitin ligase complexes regulates RET isoform internalization.A non-canonical function of Plk4 in centriolar satellite integrity and ciliogenesis through PCM1 phosphorylation.Distinct Temporal Regulation of RET Isoform Internalization: Roles of Clathrin and AP2.RET Functions as a Dual-Specificity Kinase that Requires Allosteric Inputs from Juxtamembrane Elements.Gatekeeper Tyrosine Phosphorylation of SYMRK Is Essential for Synchronizing the Epidermal and Cortical Responses in Root Nodule Symbiosis.KIF5B-RET Oncoprotein Signals through a Multi-kinase Signaling Hub.Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma.Development of RET mutant cutaneous angiosarcoma during BRAF inhibitor therapy.A secondary RET mutation in the activation loop conferring resistance to vandetanib.The molecular basis for RET tyrosine-kinase inhibitors in thyroid cancer.Drug resistance profiles of mutations in the RET kinase domain
P2860
Q30384468-00DFFEC5-94DE-41DE-A568-EE80C7DCCB21Q34906650-38A6B011-CEB8-4489-BBEF-12D055507900Q35992910-1009D91A-F35E-451A-9F42-D3B522DAC463Q38631763-55E6F27D-72C1-4631-9346-E013D93E4EB0Q38699702-FBC3C814-6425-428F-9A94-F2BA8D0DE9F6Q38841103-F5CAEF81-D2AA-4995-99A4-EFD296261B9DQ40289950-8D87BB27-3671-437B-A95A-F4B921FC7541Q40761530-925D7AFC-8C7F-483B-9EE9-F571297D6DD7Q41505056-58EFA42F-6D21-4082-9287-8F331E7CDC1EQ45998322-C7835C49-B685-4623-9A61-439049A53C9CQ46574283-2C8BACCE-E3B4-42B8-AE96-CB1B148CD359Q49365688-B5496754-BE30-4B8C-9678-DD8281C168B2Q50085302-D01449BB-565C-413B-A313-1B22DDD882C9Q58044610-7F76DEE7-0CEB-43E8-832B-07BB1A98E22C
P2860
Oncogenic RET Kinase Domain Mutations Perturb the Autophosphorylation Trajectory by Enhancing Substrate Presentation In trans
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Oncogenic RET Kinase Domain Mu ...... ubstrate Presentation In trans
@ast
Oncogenic RET Kinase Domain Mu ...... ubstrate Presentation In trans
@en
Oncogenic RET Kinase Domain Mu ...... ubstrate Presentation In trans
@nl
type
label
Oncogenic RET Kinase Domain Mu ...... ubstrate Presentation In trans
@ast
Oncogenic RET Kinase Domain Mu ...... ubstrate Presentation In trans
@en
Oncogenic RET Kinase Domain Mu ...... ubstrate Presentation In trans
@nl
prefLabel
Oncogenic RET Kinase Domain Mu ...... ubstrate Presentation In trans
@ast
Oncogenic RET Kinase Domain Mu ...... ubstrate Presentation In trans
@en
Oncogenic RET Kinase Domain Mu ...... ubstrate Presentation In trans
@nl
P2093
P2860
P3181
P1433
P1476
Oncogenic RET Kinase Domain Mu ...... ubstrate Presentation In trans
@en
P2093
Annabel Borg
Iván Plaza-Menacho
Judith Murray-Rust
Karin Barnouin
Kerry Goodman
Neil Q McDonald
Phillip Knowles
P2860
P304
P3181
P356
10.1016/J.MOLCEL.2014.01.015
P577
2014-03-06T00:00:00Z